By Stephanie Brown HealthDay ReporterTHURSDAY, July 10, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising ...

When the FDA unexpectedly uploaded around 200 drug rejection letters this week, the regulator provided an in-depth view | ...

Chief Del Manak says officers are concerned about making arrests for drug consumption that would lead to no charges, which ...

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

The U.S. Food and Drug Administration on Thursday publicly shared over 200 archived so-called complete response letters ...

Florida’s importation program hasn’t brought in a single Canadian drug. It’s not cost-effective and it could be dangerous.

The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public ...

FDA says the move boosts regulatory transparency, offering insights into common approval barriers in drug applications and reducing guesswork.

US FDA accepts for review Milestone Pharma’s response to CRL for Cardamyst nasal spray: Montreal Monday, July 14, 2025, 11:00 Hrs [IST] Milestone Pharmaceuticals Inc., a biophar ...

FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...

UK Health Agency warns that certain medications increase heat risks. These drugs affect body's cooling mechanisms. Medicines ...